CELLDEX THERAPEUTICS INC NEW - COM (CLDX)

CUSIP: 15117B103

Q3 2016 13F Holders as of 30 Sep 2016

Type / Class
Equity / COM
Total 13F shares
69,756,748
Share change
-9,472,192
Total reported value
$281,693,259
Put/Call ratio
126%
Price per share
$4.04
Number of holders
133
Value change
-$41,935,150
Number of buys
57
Number of sells
60

Quarterly Holders Quick Answers

What is CUSIP 15117B103?
CUSIP 15117B103 identifies CLDX - CELLDEX THERAPEUTICS INC NEW - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CELLDEX THERAPEUTICS INC NEW - COM (CLDX) as of Q3 2016

As of 30 Sep 2016, CELLDEX THERAPEUTICS INC NEW - COM (CLDX) was held by 133 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 69,756,748 shares. The largest 10 holders included FMR LLC, VANGUARD GROUP INC, FRANKLIN RESOURCES INC, STATE STREET CORP, BlackRock Fund Advisors, COLUMBIA WANGER ASSET MANAGEMENT LLC, DEUTSCHE BANK AG\, BlackRock Institutional Trust Company, N.A., Numeric Investors LLC, and NORTHERN TRUST CORP. This page lists 133 institutional shareholders reporting positions in this security for the Q3 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.